Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Breast Reconstruction Study Shows More Natural-Looking Breasts, Lower Risk of Surgical Complications When Using Allograft Tissue With Breast Implants
  • USA - English


News provided by

Northern Westchester Hospital

Jul 28, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Michael Rosenberg, MD, FACS, Chief of Plastic Surgery and Associate Medical Director at NWH
Michael Rosenberg, MD, FACS, Chief of Plastic Surgery and Associate Medical Director at NWH

Mt. Kisco, New York (PRWEB) July 28, 2014 -- Northern Westchester Hospital (NWH) is pleased to announce that the study, “Breast Reconstruction With or Without Human Acellular Dermal Matrices: A Single-Clinic Review of Esthetic Outcomes and Risk Factors for Complications,” was published in The American Journal of Cosmetic Surgery. The study, one of the largest ever completed on this topic, was conducted by Northern Westchester Hospital Breast and Plastic Surgeons and examined 881 breast reconstructions over a five-year period. The lead author of the paper was Michael H. Rosenberg, MD and was co-authored by David A. Palaia, MD; Anthony C. Cahan, MD; Karen S. Arthur, MD; Danielle M. DeLuca-Pytell, MD; and Philip C. Bonanno, MD.

Results from this study demonstrate that women experience better overall aesthetic results from breast reconstruction surgery when allograft tissue is used in conjunction with breast implants. Specifically, the analysis showed that women experience more natural-looking, symmetrical breasts, while having a low risk of surgical complications.

Breast cancer remains one of the top three most commonly diagnosed cancers among women in the United States, with an estimated 232,340 new cases in 2013. A large number of these patients undergo surgical treatment to successfully treat their cancer. Helping patients to maintain their confidence and self-esteem after overcoming cancer is an important consideration for all breast surgeons.

“Breast reconstruction has become increasingly important in the total treatment of women with breast cancer,” said Dr. Michael H. Rosenberg, FACS, Chief of Plastic Surgery and Associate Medical Director at Northern Westchester Hospital. “Of course, the priority is to cure the cancer. However, re-establishing quality of life and making survivorship as normal as possible is an important modern goal of cancer treatment. When the focus is on the woman with cancer, rather than the cancer itself, breast reconstruction becomes very important.”

Breast implants are the most common choice for women undergoing reconstruction and the achievement of ever-better aesthetic results is contributing to their popularity. Two of the most important advances in breast reconstruction are (1) the development of better and safer silicone-gel implants; and (2) the use of allograft in breast reconstruction. Allograft is human tissue, not from the woman herself, such as human acellular dermal matrix (HADM). Dermal matrix is the undersurface of human skin, which provides a very natural result. Acellular means all cells are removed from the dermal substance, leaving only its matrix, or lattice-like structure. Without cells, there is no potential to carry over organisms, such as a virus, or stimulate an immune response.

“If this study helps provide women with the knowledge and reassurance that breast reconstruction is readily available, affordable, effective, and helps them return to a normal life after cancer, we will have achieved something wonderful,” added Dr. Rosenberg.

Results show that in both of the HADM groups, the raters noted superior contour in the reconstructed breasts, as well as better position of the implant compared to the no-HADM group. The better aesthetic result was independent of which HADM was used. The perceived aesthetic scores were significantly higher for both the FlexHD and AlloDerm groups, as compared with the no-HADM group. To view a video of Dr. Rosenberg discussing the study, click here. The study can be found in the March 2014 edition of The American Journal of Cosmetic Surgery.

About Northern Westchester Hospital
Northern Westchester Hospital(NWH) provides high-quality, surgically-sophisticated, patient-centered care in Westchester County through a unique combination of medical expertise, leading-edge technology, and a commitment to humanity. More than 700 highly-skilled physicians, state-of-the-art technology and professional caregivers are all in place to ensure that you and your family receive treatment in a caring, respectful and nurturing environment.

NWH has established extensive internal quality measurements that surpass the standards defined by the Centers for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA). Our New York surgeons uphold highest quality standards, helping to ensure that the treatment you receive at NWH is among the best in Westchester County and the nation. For a complete list of our services, please visit http://www.nwhc.net.

###

Contact:
Gretchen Mullin
Associate Director, Marketing & Communications
Northern Westchester Hospital
(914) 666-1266

Mark Vincent, Northern Westchester Hospital, +1 (914) 666-1295, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.